Trademarkia Logo

United Kingdom

£
Registered

on 10 Oct 2018

Last Applicant/ Owned by

Crinetics Pharmaceuticals, Inc.

6055 LUSK BLVD

San Diego, California, 92121

Serial Number

UK00917966767 filed on 10th Oct 2018

Registration Number

UK00917966767 registered on
19th Jul 2019

Correspondent Information

Finnegan Europe LLP

1 London Bridge

London,

SE1 9BG

CRINETICS

pharmaceutical preparations for modulating neuropeptides and g-protein coupled receptors (gpcrs); pharmaceutical preparations for use in oncology; pha Read More

Classification Information


Class [5]
Pharmaceutical Products


Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers, tumors, malignancies and neoplasms; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to treat or prevent dermatological, cardiovascular, hematological, bone, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceuticals to target neuropeptide receptors; pharmaceuticals for treating acromegaly, neuroendocrine tumors, cancers, malignancies and neoplasms, Cushing's Disease, hyperinsulinism, and chronic pain.

Class [42]
Computer & Software Services & Scientific Services


Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others.

Mark Details


Serial Number

UK00917966767

Mark Type

Word

Kind of mark

Individual